92 related articles for article (PubMed ID: 20382150)
1. ELISA for antiphosphatidylethanolamine antibody detection: high impact of assay buffer on results.
Sanmarco M
J Immunol Methods; 2010 Jun; 358(1-2):9-16. PubMed ID: 20382150
[TBL] [Abstract][Full Text] [Related]
2. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.
Boffa MC; Berard M; Sugi T; McIntyre JA
J Rheumatol; 1996 Aug; 23(8):1375-9. PubMed ID: 8856616
[TBL] [Abstract][Full Text] [Related]
3. The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.
Hou S; Harper PE; Bardin N; Zhao M
J Immunol Methods; 2017 Jan; 440():27-34. PubMed ID: 27784626
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
Sugi T; McIntyre JA
Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE).
Bertolaccini ML; Murru V; Sciascia S; Sanna G; Khamashta MA
Thromb Res; 2012 Dec; 130(6):914-8. PubMed ID: 23079292
[TBL] [Abstract][Full Text] [Related]
6. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
Sanmarco M; Boffa MC
Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
[TBL] [Abstract][Full Text] [Related]
7. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases.
Berard M; Chantome R; Marcelli A; Boffa MC
J Rheumatol; 1996 Aug; 23(8):1369-74. PubMed ID: 8856615
[TBL] [Abstract][Full Text] [Related]
8. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.
Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR
J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579
[TBL] [Abstract][Full Text] [Related]
9. Detection of anti-phosphatidylethanolamine antibodies using flow cytometry.
Drouvalakis KA; Neeson PJ; Buchanan RR
Cytometry; 1999 May; 36(1):46-51. PubMed ID: 10331626
[TBL] [Abstract][Full Text] [Related]
10. [IGM hyperimmunoglobulinemia anti-phosphatidylethanolamine antibodies of the IgM isotype: clinical and biological study of 72 patients with immune disorders].
Granel B; Serratrice J; Hubert AM; Volot F; Pache X; Swiader L; Rossi P; Disdier P; Weiller PJ
Rev Med Interne; 2000 Jul; 21(7):595-8. PubMed ID: 10942975
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses.
Sanmarco M; Alessi MC; Harle JR; Sapin C; Aillaud MF; Gentile S; Juhan-Vague I; Weiller PJ
Thromb Haemost; 2001 May; 85(5):800-5. PubMed ID: 11372671
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
13. Can cryoglobulins interfere with the measurement of IgM antiphosphatidylethanolamine antibodies by ELISA?
Bardin N; Pommier G; Sanmarco M
Thromb Res; 2007; 119(4):441-6. PubMed ID: 16766022
[TBL] [Abstract][Full Text] [Related]
14. Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities.
Ogawa H; Zhao D; Dlott JS; Cameron GS; Yamazaki M; Hata T; Triplett DA
Am J Clin Pathol; 2000 Oct; 114(4):619-28. PubMed ID: 11026109
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of phospholipid-specific assays for the evaluation of antiphospholipid syndrome.
Tebo AE; Jaskowski TD; Phansalkar AR; Litwin CM; Branch DW; Hill HR
Am J Clin Pathol; 2008 Jun; 129(6):870-5. PubMed ID: 18480002
[TBL] [Abstract][Full Text] [Related]
16. Anti-phosphatidylethanolamine (aPE) antibodies: a survey.
Mcintyre JA; Wagenknecht DR
J Autoimmun; 2000 Sep; 15(2):185-93. PubMed ID: 10968907
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
18. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
19. [Which place of antiphosphatidylethanolamine antibodies research in seronegative antiphospholipid syndrome suspicion?].
Billoir P; Miranda S; Abboud J; Armengol G; Levesque H; Benhamou Y; Le Cam Duchez V
Rev Med Interne; 2019 Jun; 40(6):351-354. PubMed ID: 30905593
[TBL] [Abstract][Full Text] [Related]
20. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
